BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25560643)

  • 1. Quantitative proteomics of bronchoalveolar lavage fluid in lung adenocarcinoma.
    Almatroodi SA; McDonald CF; Collins AL; Darby IA; Pouniotis DS
    Cancer Genomics Proteomics; 2015; 12(1):39-48. PubMed ID: 25560643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
    Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
    J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
    Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
    Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers.
    Sim SY; Choi YR; Lee JH; Lim JM; Lee SE; Kim KP; Kim JY; Lee SH; Kim MS
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900028. PubMed ID: 31119868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.
    Vu HM; Mohammad HB; Nguyen TNC; Lee JH; Do Y; Sung JY; Lee SH; Kim MS
    Proteomics Clin Appl; 2023 Sep; 17(5):e2300011. PubMed ID: 36807835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS-Based Biomarker Discovery in Bronchoalveolar Lavage Fluid for Lung Cancer.
    Matthiesen R
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900077. PubMed ID: 31631581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
    Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
    Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.
    Hmmier A; O'Brien ME; Lynch V; Clynes M; Morgan R; Dowling P
    BBA Clin; 2017 Jun; 7():97-104. PubMed ID: 28331811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A label-free differential proteomic analysis of mouse bronchoalveolar lavage fluid exposed to ultrafine carbon black.
    Chiu KH; Lee WL; Chang CC; Chen SC; Chang YC; Ho MN; Hsu JF; Liao PC
    Anal Chim Acta; 2010 Jul; 673(2):160-6. PubMed ID: 20599030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma.
    Ruppert AM; Baud L; Rabbe N; Perez J; Duruisseaux M; Vieira T; Antoine M; Cadranel J; Wislez M
    Bull Cancer; 2019 Mar; 106(3):179-188. PubMed ID: 30683309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma.
    Wiedl T; Arni S; Roschitzki B; Grossmann J; Collaud S; Soltermann A; Hillinger S; Aebersold R; Weder W
    J Proteomics; 2011 Sep; 74(10):1884-94. PubMed ID: 21596165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
    Foster MW; Morrison LD; Todd JL; Snyder LD; Thompson JW; Soderblom EJ; Plonk K; Weinhold KJ; Townsend R; Minnich A; Moseley MA
    J Proteome Res; 2015 Feb; 14(2):1238-49. PubMed ID: 25541672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases.
    Carvalho AS; Matthiesen R
    Methods Mol Biol; 2017; 1619():487-494. PubMed ID: 28674906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preliminary Study of Microbiota Diversity in Saliva and Bronchoalveolar Lavage Fluid from Patients with Primary Bronchogenic Carcinoma.
    Wang K; Huang Y; Zhang Z; Liao J; Ding Y; Fang X; Liu L; Luo J; Kong J
    Med Sci Monit; 2019 Apr; 25():2819-2834. PubMed ID: 30994108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.
    Kosanam H; Sato M; Batruch I; Smith C; Keshavjee S; Liu M; Diamandis EP
    Clin Biochem; 2012 Feb; 45(3):223-30. PubMed ID: 22206736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
    Li QK; Shah P; Li Y; Aiyetan PO; Chen J; Yung R; Molena D; Gabrielson E; Askin F; Chan DW; Zhang H
    J Proteome Res; 2013 Aug; 12(8):3689-96. PubMed ID: 23802180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.